Indoco Remedies gets USFDA’s approval for Cetirizine Hydrochloride Tablets

04 Oct 2024 Evaluate

Indoco Remedies has received final approval from the US Food and Drug Administration (USFDA) for Abbreviated New Drug Application (ANDA) for Cetirizine Hydrochloride Tablets USP, 10 mg (OTC), a generic equivalent of the Reference Listed Drug, Zyrtec Allergy Tablets, 10 mg of Johnson & Johnson Consumer Inc.

Cetirizine Hydrochloride Tablets USP, 10 mg will be manufactured by the company, at their manufacturing facility located at L-14, Verna Industrial Area, Verna, Goa. Cetirizine is used for relief of symptoms of hay fever and other allergic conditions.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.


Indoco Remedies Share Price

339.15 4.10 (1.22%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.